AbCellera Biologics Inc. Annual Amortization of Intangible Assets in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
AbCellera Biologics Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from 2019 to 2023.
  • AbCellera Biologics Inc. Amortization of Intangible Assets for the quarter ending March 31, 2024 was $1.69M, a 36.4% decline year-over-year.
  • AbCellera Biologics Inc. annual Amortization of Intangible Assets for 2023 was $11.6M, a 10.5% increase from 2022.
  • AbCellera Biologics Inc. annual Amortization of Intangible Assets for 2022 was $10.5M, a 3.96% increase from 2021.
  • AbCellera Biologics Inc. annual Amortization of Intangible Assets for 2021 was $10.1M, a 304% increase from 2020.
Amortization of Intangible Assets, Annual (USD)
Amortization of Intangible Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $11.6M +$1.1M +10.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-20
2022 $10.5M +$400K +3.96% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-20
2021 $10.1M +$7.6M +304% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-20
2020 $2.5M +$2.5M Jan 1, 2020 Dec 31, 2020 10-K 2023-02-21
2019 $0 Jan 1, 2019 Dec 31, 2019 10-K 2022-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.